about
Mesangial cells stimulate differentiation of endothelial cells to form capillary-like networks in a three-dimensional culture system.Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation.Successful treatment of severe crescentic lupus nephritis by multi-target therapy using tacrolimus and mycophenolate mofetilNephrotic syndrome caused by immune-mediated acquired LCAT deficiencyInvolvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstructionGlomerular cytokine expression in murine lupus nephritis.Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats.Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.Enhancement of in vitro human tubulogenesis by endothelial cell-derived factors: implications for in vivo tubular regeneration after injury.Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury.Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.Extremely high levels of C-reactive protein in patients with acute lupus serositis.SIRPα signaling regulates podocyte structure and function.Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.Five patients who died during treatment for adult Still's disease.Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.Angiotensin II Type 1 Receptor Blockade Inhibits the Development and Progression of HIV-Associated Nephropathy in a Mouse ModelHypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patientsHepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature ReviewEnhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNFIs sulfite an antiatherogenic compound in wine?Increased levels of serum sulfite in patients with acute pneumoniaIncreased expression of cell adhesion kinase beta in human and rat crescentic glomerulonephritisHydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener's)[Case report: posterior reversible encephalopathy syndrome and scleroderma renal crisis developed in a patient with overlap syndrome after treatment with high-dose steroids and tacrolimus]Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapyA case of ANCA-negative renal small-vessel vasculitis with tubulointerstitial infiltration of IgG4-positive plasma cellsClinical and histological features of lupus nephritis in Japan: A cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR)TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytesThe Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the LiteratureAttenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channelUrinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis[Lupus nephritis and nephrotic syndrome: diagnosis and treatment]
P50
Q31128716-F36966C5-8C75-4830-B29A-FDAC526C7D05Q33327323-CE260059-00C8-4EAE-8661-B59522108454Q33628340-3586B1D4-0385-4335-9AE1-837AA36995A4Q37078417-B7DEFCBB-DD1D-4469-8FFD-BAF8EA6F3392Q39158030-CDA68A61-4A2D-4534-9129-ED07B7D684C4Q39764178-1403074C-240B-48AB-9BF7-7B5B387601BBQ40927712-7EAA3FD2-9054-4557-AE91-DC60D1290C8CQ41193260-F184EE73-394D-4400-AB71-9CE4CF08F831Q42448757-04E854F5-06E7-437F-9216-0A1FDC338304Q43776037-C94F3E76-F6F5-4113-B489-E2996E2D6119Q44142908-B166FC65-57EE-495C-B4ED-1ABA5068B6C9Q44586784-A4F217FA-B54A-4FFE-9486-9A38F8F8B6E1Q46663006-246CEE64-DA85-4E1F-B410-24F430D4FBFAQ47702650-D08D3CD3-BA8F-46CC-BB3A-A70658AEC026Q48030981-5D41327C-D459-44CB-9574-693516DA73FFQ49218097-A3007BFC-693B-4FF3-A119-988F86C246D4Q50098290-1E8215C7-FA3A-488D-85DA-C2B05CEB74C5Q50201846-14D48D92-5783-47BB-9F57-B927EBC8B31DQ50904967-1B9BF477-6789-491B-8F94-8CA1EC068942Q52340965-D99B8E64-508C-49C6-8451-BE96258B4E62Q54571803-46CE0FCC-8471-401E-8675-9D818139F694Q57691250-8D60C71F-3E0C-48F1-9AEF-E3ECE3625AC8Q58612311-8E976314-2280-41AC-AE93-4C5C16EB9C52Q59353839-8D95EA7D-66B1-4052-8E3E-95CB09BE258BQ64123214-956EE08B-9E46-4B3B-AD17-36D611B232DAQ74542361-3FCB7010-2CDE-4854-9FDA-5DAB2F80CF7DQ75367466-0608CA8F-4D0B-4D8C-9C8F-9305DD4CA730Q77440677-F0AD8583-BDA6-4FAD-80BA-1673E0D31122Q82416765-954D09F3-5975-4045-BC75-7DC7D2449997Q84808796-ECBA277C-66F6-435B-85D4-C55F3765AEBEQ87555098-B375AF60-6342-47C7-8061-FCE4689C9B36Q87908742-7FBE9304-D690-4DD8-B6B5-428F5D6BC0AFQ88008158-C4A8988E-BDCD-4876-9D7C-1FE1164C31A9Q88931291-32D6F2D8-A5ED-4BB3-B075-190C9461F7F6Q89019402-79550FED-B153-42D7-9ABF-913CC05B029BQ90611060-A9CE9831-F719-40C5-9F86-44A1362F269BQ90717066-488780EF-5594-46C9-B5A8-0C1F9E469892Q95413979-AA99FFD7-BB76-41E9-9ED9-D52432FBA9AD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hidekazu Ikeuchi
@ast
Hidekazu Ikeuchi
@en
Hidekazu Ikeuchi
@es
Hidekazu Ikeuchi
@nl
type
label
Hidekazu Ikeuchi
@ast
Hidekazu Ikeuchi
@en
Hidekazu Ikeuchi
@es
Hidekazu Ikeuchi
@nl
prefLabel
Hidekazu Ikeuchi
@ast
Hidekazu Ikeuchi
@en
Hidekazu Ikeuchi
@es
Hidekazu Ikeuchi
@nl
P106
P31
P496
0000-0002-0768-7090